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Empire and Alternatives:
Swietenia febrifuga and the Cinchona Substitutes
PRATIK CHAKRABARTI*
Introduction
This paper focuses on a cinchona substitute, the Swietenia febrifuga (also known as
Soymida febrifuga
1), whose medical virtues for treating intermittent fevers were discov-
ered in India around 1791 by William Roxburgh, the English East India Company
(EEIC) surgeon in charge of the Company’s botanical garden in Samulcottah (north of
Chennai or Madras). The bark was subsequently subjected to several experiments in
three main cities, Samulcottah, Madras (the EEIC headquarters on the east coast of India)
and Tranquebar (the Danish base on the same coast). The research and promotion of the
bark were carried out by Roxburgh, other surgeons, missionaries and also the EEIC’s
commercial agents.
One reason for such an interest in the bark was the commercial incentive to find local
alternatives to cinchona. Monopolies of trade required availability and cultivability of
similar species of commercial commodities within areas of control. Another was scien-
tific. The bark promised a cure for a major disease for Europeans in the colonies and
the search for a substitute had become a global scientific obsession. For botanists like
Roxburgh, who were based in India, the discovery of a cinchona substitute was one of
the few ways of achieving international recognition. Moreover, the scientific ambiguity
of the most suitable species of cinchona prompted the trial of many alternatives in differ-
ent regions.
By focusing on the identification and scientific analyses of Swietenia and other similar
substitutes, both in India and in England, this paper first investigates the trajectories of
the search for medical alternatives in the empire through the burgeoning networks of
trade and natural history. It then studies the other aspect of this process; an analytical
contraction, whereby many such alternatives were chemically reduced to their active
components in Europe. This addresses a historiographical issue; the need to re-emphasize
the epistemological authority of Europe—and its scientific institutions—which emerged
as the metropolis of science in this period. Over the last few decades, writings in the
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75history of science have increasingly defined the periphery in terms of its diverse dyna-
mism.
2 Such works have been informed to an extent by the emerging literature on
imperialism which has highlighted the dynamic and regenerative aspects of colonial
encounters, particularly of the eighteenth century, in an attempt to mark these local
histories as important sites of global understanding.
3 Historians of science have subse-
quently stressed the need to understand the creativity and vitality of colonial knowledge
systems. They have asserted that modern science in colonial India was a product of the
intercultural encounter between South Asians and Europeans.
4 Others have located the
roots of present global ecological concerns in the emergence of ecological thought
from within colonial localities.
5 However, reorienting the problematic of science from
Europe to the colonies need not necessarily lead to a realignment of its intellectual capi-
tal. As this paper shows, the rejection of the alternatives to cinchona or the Peruvian bark
was the result of the dominance of a metropolitan scientific method, which counteracted
the diverse creativity of the periphery. Along with the searches for medical alternatives
in the empire through the burgeoning networks of natural history, Europe had also under-
taken various methods of analysis, particularly with the emergence of modern chemistry.
This dynamic of the search for alternatives in the periphery and their analysis in the
metropolis was crucial to the emergence of not only cinchona as a panacea but also of
modern therapeutics.
From the seventeenth century, cinchona has occupied an important position in the
European pharmacopeia. It has a fascinating history starting from its discovery by
Europeans in South America, its uses and its transmission and distribution throughout
Europe and other continents. In the eighteenth century, there was a frantic search for
the true species of the tree that produced the Peruvian bark. Increased demand, rising
prices and confusion over the identity of the tree made it essential to locate it in its
native habitat. In 1735, the French government sent an expedition under Charles Marie
de la Condamine to South America, ostensibly to measure the arc of the meridian at
Quito in Ecuador to determine the diameter of the earth, but also to search for the fever
tree. Condamine succeeded in finding the cinchona tree about 20 miles from Loxa, in
Peru.
6
There is another aspect to this history. The eighteenth century was a period of global
search for alternatives. In therapeutic remedies this was particularly reflected in the
2See Mark Harrison, ‘Science and the British
empire’, Isis, 2005, 96: 56–63; Roy MacLeod, ‘On
visiting the “moving metropolis”: reflections on the
architecture of imperial science’, in Nathan Reingold
and Marc Rothenberg (eds) Scientific colonialism:
a cross-cultural comparison, Washington, DC,
Smithsonian Institution Press, 1987, pp. 217–49.
3C A Bayly, Imperial meridian: the British
empire and the world, 1780–1830, London, Longman,
1989, p. 10. See also Phillip B Wagoner, ‘Precolonial
intellectuals and the production of colonial
knowledge’, Comparative Studies in Society and
History, 2003, 45: 783–814, p. 783; Thomas
Trautmann, ‘Inventing the history of South India’, in
Daud Ali (ed.), Invoking the past: the uses of history
in South Asia, New Delhi, Oxford University Press,
1999, 36–54; Eugene F Irschick, Dialogue and
history: constructing South India, 1795–1895,
Berkeley, University of California Press, 1994.
4Kapil Raj, Relocating modern science:
circulation and the construction of scientific
knowledge in South Asia and Europe, seventeenth to
nineteenth centuries, Delhi, Permanent Black, 2006.
5Richard H Grove, Green imperialism: colonial
expansion, tropical island Edens and the origins of
environmentalism, 1660–1800, Cambridge University
Press, 1995.
6M R Lee, ‘Plants against malaria. Part 1:
Cinchona or the Peruvian bark’, J. R. Coll. Physicians
Edinb., 2002, 32: 189–96, pp. 191–2.
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76interest in substitutes for cinchona. For the British, with no colonial base in the South
American continent, the imperative was to locate alternatives to cinchona in their own
colonies. Several such plants were discovered by British surgeons in the West Indies.
In St Lucia, George Davidson found trees very similar to the Cinchona officinalis.
7
In Jamaica, William Wright, the Surgeon-General, discovered the Cinchona caribæa.
8
Wright had also identified the plant which yielded the Simaruba bark (a native of
northern Brazil, Guyana and some West Indian islands), and sent a drawing and a
description of it to Dr Hope, professor of botany at Edinburgh.
9 When he returned to
Edinburgh, he carried with him what the Medical and Philosophical Commentaries
described as a “large collection of natural curiosities”, among them specimens of the
new species of Peruvian bark.
10 The Cinchona triflora was discovered by Mr Roberts,
a clergyman in Jamaica; while Mr Lindsay, a surgeon, came across the Cinchona brachy-
carpa in the parish of Westmoreland, Jamaica, in 1785.
11 Many such alternatives were
also found in the Indian subcontinent. These discoveries involved interactions between
indigenous practitioners, Jesuit missionaries and European surgeons and botanists,
some of which will be discussed in the course of this paper.
12 In fact the literature pro-
duced in this period on the alternatives to cinchona was almost as extensive as that on
cinchona itself.
While the search for cinchona has been well documented, along with the history of
quinine, the history of alternatives to febrifuges has received little scholarly attention.
13
The only account is an informative but brief article by Mark Harrison.
14 Simultaneously,
there has also been a trend to follow the history of cinchona in a teleological fashion,
from the seventeenth century to its global propagation in the nineteenth. Saul Jarcho’s
very interesting book Quinine’s predecessor focuses particularly on the history of cin-
chona, from the days of its discovery by Europeans. What has been left completely
untraced is the history of the alternatives, and the question that remains to be asked is:
how did the alternatives get lost?
7George Davidson, communicated by Donald
Monro, ‘An account of a new species of the bark-tree,
found in the Island of St. Lucia’, Phil. Trans. R. Soc.
Lond., 1784, 74: 452–6.
8A memoir of the late William Wright, with
extracts from his correspondence, and a selection of
his papers on medical and botanical subjects,
Edinburgh and London, William Blackwood, 1828,
p. 199.
9William Wright, A botanical and medical
account of the Quassia simaruba, or tree which
produces the cortex simaruba, Edinburgh, 1778.
10‘Medical News’, Medical and Philosophical
Commentaries, 1778, 5: 218.
11A memoir of the late William Wright, op. cit.,
note 8 above, p. 200.
12Mark Harrison, ‘The discovery of indigenous
febrifuges in the British East Indies, c.1700–1820’, in
Merlin Willcox, Gerard Bodeker; Philippe
Rasoanaivo; Jonathan Addae-Kyereme (eds),
Traditional medicinal plants and malaria, Boca
Raton, CRC Press, 2004, pp. 199–203.
13Saul Jarcho, Quinine’s predecessor: Francesco
Torti and the early history of cinchona, Baltimore,
Johns Hopkins University Press, 1993; Donovan
Williams, ‘Clements Robert Markham and the
introduction of the Cinchona tree into British India’,
Geog. J., 1962, 128: 431–42; Fiammetta Rocco, The
miraculous fever-tree: malaria, medicine and the cure
that changed the world, London, Harper Collins,
2003; M Honigsbaum, The fever trail: in search of
the cure for malaria, New York, Farrar, Straus and
Giroux, 2001.
14Harrison, op. cit., note 12 above.
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77William Roxburgh and his Fever Bark
Roxburgh published a treatise on the newly discovered Swietenia febrifuga in 1793,
with the aim of persuading the Court of Directors of the EEIC in London to promote
its use as an alternative to the Peruvian bark.
15 The treatise included an account of the
detailed chemical researches that he had undertaken to establish the qualities of the
bark. He had experimented with chalybeate, limewater, vitriolic acid, vinegar, mild or
caustic vegetable alkali and magnesia and found that the antiseptic powers of this bark
were directly proportional to its bitter and astringent virtues.
16 Roxburgh’s conclusions
were that the active parts of the Swietenia were more soluble than those of the Peruvian
bark, it contained a much larger proportion of the active (bitter and astringent) powers,
and the watery preparation of the bark remained potent much longer than similar pre-
parations of the Peruvian bark.
17
Roxburgh’s conclusions were drawn from outside the laboratory as well, from an
Anglo-Danish-German network of surgeons and missionaries who carried out trials and
experiments on the bark in the Madras presidency. Soon after its discovery in 1791, he
sent samples of Swietenia bark to his trusted German-Danish missionary friend, the
Reverend Christopher Samuel John, in Tranquebar, for trials in the local hospitals and
by the mission surgeons. In 1792, John reported that he had given the bark to the mission
doctors T L F Folly and J G Klein to try preparations from it on the patients in their hos-
pital. He had also given it to a fellow missionary, Johan Peter Rottler, who had a strong
interest in the natural history of the region, and had commented, “Your Bark Swietenia
Febrifuga gets here the highest reputation by Dr Klein and Dr Folly.” Rottler also asked
for seeds of the tree, adding that the missionaries planned to send it to Copenhagen.
18
In November 1792, John mentioned that eighty samples of the bark had been sent to
Professors Winslow and Jade at Copenhagen, “both of high reputation”.
19 More news
of success locally was forthcoming; with Roxburgh’s bark, the surgeon at Tranquebar
had cured Rottler who had almost died from intermittent fever.
20
Within the Madras medical establishment, Andrew Ross, an EEIC merchant based in
Madrasandacollaborator ofRoxburghinhisbotanicalpursuits,helpedtopromoteSwietenia
bark among the surgeons in the town and elsewhere in the Presidency. He informed
Roxburgh that William Duffin at the Madras hospital had found the substance useful, and
promised to obtain a declaration from him, which he would then send to England.
21
15William Roxburgh, ‘A botanical description of
a new species of Swietenia (mahogany) with
experiments and observations on the bark thereof, in
order to determine and compare its powers with those
of Peruvian Bark for which it is proposed as a
substitute’, addressed to the Honourable Court of
Directors of the United East-India Company by their
most obedient humble servant Wm Roxburgh,
London, 1793. Two copies of this publication are held
in the British Library.
16Ibid, p. 16. In the pre-quinine days astringency
was considered to be the active principle of “fever
barks”.
17Ibid.
18Ibid.
19Christopher S John to William Roxburgh,
26 Nov. 1792, British Library (hereafter BL), Asia,
Pacific and Africa Collections (hereafter APAC),
MSS. Eur D 809. John was probably referring to
Frederik Christian Winslow, surgeon-in-chief to the
Royal Frederic Hospital, Copenhagen. He was
famous for his pioneering vaccination work in
Denmark, see, E D V Gotfredsen, ‘Some relations
between British and Danish medicine in the
seventeenth and eighteenth centuries’, J. Hist. Med.
Allied Sci., 1953, 8: 46–55, p. 55.
20Christopher S John to William Roxburgh,
26 Nov. 1792, BL, APAC, MSS. Eur D 809.
21Andrew Ross to William Roxburgh, 17 July
1792, Madras, Botany Library, Natural History
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78In early 1793, Ross discussed the new remedy with Charles Oakley (President of the
Madras Council of the EEIC), who suggested that Roxburgh should approach the Madras
Hospital Board, the Company’s main medical regulatory authority of the Presidency,
for its official endorsement.
22 Roxburgh accordingly sent the bark to James Anderson
Figure 1: Swietenia febrifuga, from William Roxburgh, Plants of the coast of Coromandel ...
published under the direction of Sir Joseph Banks, London, George Nicol, 1795–1819, vol. 1,
p. 17.
Museum, London (hereafter NHM), MSS ROX, 1793;
Andrew Ross to Roxburgh, 6 Oct. 1791, Madras,
NHM, MSS ROX, 1793.
22Andrew Ross to William Roxburgh, 5 Jan.
1793, Madras, NHM, MSS ROX, 1793.
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79(Surgeon-General and President of the Board).
23 Additionally, Valentine Conolly, Secretary
to the Hospital Board, forwarded the bark to the head surgeons of the provinces, William
Raine, Terence Gahagan, George Binny and Nicol Mein, asking them to try it on patients
in their local hospitals so that its “virtues may be more fully ascertained”, and to send the
results to Madras.
24
Gahagan promised to try the bark.
25 Mein mentioned that his initial experiments sug-
gested that the substance contained a higher degree of astringency than the Peruvian
one.
26 Binny wrote back that he had already heard of the bark from Roxburgh and had
tried it successfully in some cases.
27 In June 1793, Mein confirmed his success with
Swietenia, “the cure of the Intermittent fevers corroborates Dr Roxburgh’s observations
and I hope will prove satisfactory to the Physician General and the Members of the
Hospital Board”.
28
Ross kept Roxburgh, who was still based in remote Samulcottah, informed about the
progress of the experiments on the bark and the promise of doctors in Madras to promote
its use: “Dr Berry has read your dissertation upon it & will also support it.”
29 But appar-
ently impatient with the delay in receiving confirmation from the Company hospitals,
Roxburgh seems to have suggested that Ross offer Dr Berry a share of any profits
from sales of the bark, in return for a prompt acknowledgment. Ross restrained Roxburgh
saying that such a step “would amount to an indirect acknowledgement that its
[Swietenia’s] intrinsick [sic] quality, was not good enough ...it would be a derogation
to your character, to take any indirect course, of bringing it to any further test, which
may be required, of public enquiry”.
30 He also kept his faith in Anderson and the Madras
establishment, “and I have no reason to doubt, that the means which Dr Anderson is
pursuing ...of ascertaining the true character of the Bark—is not only in due form, but
fair in intention”.
31 These were some of the methods of ascertaining the efficacy of the
bark through the acceptable means of gentlemanly science in the periphery. A few months
later, Ross wrote to Roxburgh that Dr Mein of Trichinopoly had found it very useful.
32
The same year, 1793, Ross wrote to John Forbes (senior), partner of the major ship-
ping company, Forbes & Co., in Bombay, asking him to arrange for trials of the bark
in hospitals throughout the Bombay Presidency. This new substance, he stated enthusias-
tically, was believed to be as good as, if not better than, the Peruvian bark, and it
had already met with success in Madras.
33 Ross stressed the great benefits to both com-
merce and medicine if such a product could be procured fresh in India. The greatest
advantage would be “by its being the produce of the Company’s own estate instead of
23William Roxburgh to James Anderson and the
Madras Hospital Board, 17 Feb. 1793, Surgeon
General’s Records (hereafter SGR), Tamil Nadu State
Archive, Chennai, vol. 9, p. 24.
24Valentine Conolly to Messrs. Raine, Gahagan,
Binny, and Mein, 5 Mar. 1793, ibid., p. 21.
25Terence Gahagan to Valentine Conolly,
10 March 1793, ibid., p. 22.
26Nicol Mein to Valentine Conolly, 24 March
1793, ibid., p. 28.
27George Binny to Valentine Conolly, 6 April
1793, ibid., p. 32.
28Nicol Mein to Valentine Conolly, 4 June 1793,
ibid., p. 50.
29Andrew Ross to William Roxburgh, 26 Feb.
1793, NHM, MSS ROX, 1793.
30Andrew Ross to William Roxburgh, 21 Mar.
1793, NHM, MSS ROX, 1793.
31Ibid.
32Andrew Ross to William Roxburgh,
28 Sept.1793, NHM, MSS ROX, 1793.
33Andrew Ross to John Forbes, 2 Nov. 1793,
NHM, MSS ROX, 1793.
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80the large imbursement of its value which is made to another nation”.
34 Ross sent a good
quantity of Swietenia bark to Forbes so that trials could be carried out in both the hospi-
tals in the city of Bombay and the provinces, as had been done in Madras. He also men-
tioned that Roxburgh intended to test it in places like Constantinople, where intermittent
fever was reported to be rampant and where there was a strong presence of European
medical men. He hoped that this would be a way for it to become known among physi-
cians in Europe as well. While approval from the Madras Board was important for local
use of the bark, Europe was the prime site for Swietenia’s recognition. Ross asked Forbes
to use his trading networks to send the bark to:
such nations within your reach where those complaints are most frequent to the cure of which
that remedy is applied & to procure reports of its efficacy from the physical gentlemen who reside
there ... It can be sent forward to such parts to the Westward, through the Gulphs of Persia &
Mocha & towards the Turkish Dominions where there are European Doctors & where it may be
of most use ...
35
Despite these local corroborations and acknowledgments, recognition from Europe
had always been vital for Roxburgh and he tried to utilize his own networks to achieve
this. In 1784, before his discovery of Swietenia, he had written to Joseph Banks from
Samulcottah about the several substitutes for Peruvian bark that he had found in India.
One of them was the bark of Melia azadirachta,
36 and he found it worked “wonderfully
well”. He sent the bark and some fresh leaves to Banks. There was also the root of
Archipecus vomitoria discovered by Johann Gerhard Koenig. British officers who had
been prisoners of Hyder Ali for a long time told Koenig that when indisposed they
used the dried roots of this plant both as an eructic as well as a cathartic. They made
it up into pills of a few grains each and took one every half or three quarters of an
hour. Roxburgh also sent Banks samples of the Clitoria ternata, whose roots were
used in purgation.
37 In 1791, he sent him a package of Swietenia bark and asked him
to pass on a parcel to his friend, Patrick Russell.
38 Roxburgh wanted his discovery of
the bark to be known in English medical circles and his treatise on it to be published
in the Philosophical Transactions of the Royal Society.
39
Roxburgh also corresponded about his new bark with James Edward Smith, founder and
first president of the Linnean Society of London. In 1792 he sent Smith the “fever bark”
34Ibid.
35Ross to John Forbes, 6 Nov. 1793, NHM, MSS
ROX, 1793.
36The Neem tree, which has been widely used in
Indian medicine.
37William Roxburgh to Joseph Banks, 10 Dec.
1784, Banks Correspondence, BL, Add. MS 33977,
fols 272–3.
38William Roxburgh to Joseph Banks, 10 Dec.
1791, Banks correspondence, BL Add. MS 33979,
fols 116–17.
39Banks had replied that since it had already been
printed the Royal Society would not be willing to
republish it: “You mention in one of your letters an
intention that the paper on Swietenia should appear in
the Philosophical Transactions, whether the Commee
[sic] of papers who regulate the publications of the
R. Soc. would or would not have admitted it was
never put to the test for the Court of Directors
published it the moment it came to their hands so that
the first copy I saw was a printed one”; Joseph Banks
to William Roxburgh, 29 May 1796, Banks
correspondence, BL Add. MS 33980, fol. 66.
Roxburgh’s account did, however, appear in Medical
Facts and Observations, ‘An account of a new
species of Swietenia (mahogany); and of experiments
and observations on its bark, made with a view to
ascertain its powers, and to compare them with those
of Peruvian Bark, for which it is proposed as a
substitute’, Medical Facts and Observations, 1795,
6: 127–61.
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81throughWilliamFarquhar.
40InMarch1793,Roxburghwrote tohimagainaboutthesuccess
ofthe barkin India,“Itgives meparticularpleasuretoobservetoyou thatthe new Swietenia
bark continues to support to the utmost of my wishes, the character I first gave it, seldom
or never failing to perform speedy cures in all kinds of Remitting and Intermittent fevers,
even after the Peruvian bark had faild [sic]”. He added that the Coromandel coast was
particularly suited for such experiments as it “had abundance of cases to try it in”.
41 After
his appointment as superintendent of the Calcutta botanical garden, Roxburgh continued
to correspond with Smith. In 1794 he wrote, “I hope [the Swietenia bark] proves of equal
benefit in Europe. It has answered so well with the Batavia Fever, that the physician general
there applied for and got 1000 pounds of it a few weeks ago.”
42
What were the scientific virtues of the bark that Roxburgh sought to promote in
Europe? Andreas-Holger Maehle has suggested that a shift took place in eighteenth-
century ideas of “specifics” when a remedy was no longer defined through its single
target, such as intermittent fever, but through its uniquely powerful and not fully under-
stood mode of action, which was beneficial in a number of diseases.
43 Roxburgh pro-
moted Swietenia in Europe, keeping in mind the changing values, and claimed its
usefulness not only for malarial fevers, but also for gangrene and other putrid maladies.
He conferred with William Cullen of Edinburgh University, who had described the
recurrence of paroxysms in terms of “atony”
44 in the extremities of the arterial system
and advocated the use of simple bitters as the means to treat it. Taking these viewpoints
into consideration, Roxburgh concluded that “from the successful experience I have had
with [this new bark], in intermittent fevers, &c. I have every reason to imagine it will
prove equal, if not superior, to the Peruvian bark, for every purpose where that medicine
is used”.
45 In the same paper, Roxburgh also mentioned several plants and roots found in
India, “perfectly unknown to European botanists” that the “poor natives” of the mountai-
nous parts of the coastline consumed for their nutritional value.
46
Despite the participation in such contemporary discourses, however, scientific recog-
nition in England for the discoveries made in the colonies was not easily forthcoming,
often because of a lack of patronage. The EEIC did little to promote the scientific
work of its servants. In 1791, Roxburgh complained to the Madras government about
the failure of the Court of Directors to promote and promulgate “useful discoveries
made by their own official Servants, and in their own territories”.
47 Roxburgh also felt
aggrieved by the actions of some individuals based in London, like Alexander Dalrymple
(FRS and hydrographer to the Company and the Royal Navy), who tended to appropriate
the credit for researches done elsewhere. In a note Roxburgh accused Dalrymple of
40William Roxburgh to James E Smith, 4 Aug.
1792, 182, J E Smith Manuscripts, Linnean Society
Library, London (hereafter Linnean).
41William Roxburgh to James E Smith, 20 June,
1793, 8.184, J E Smith Manuscripts, Linnean.
42William Roxburgh to James E Smith, 14 Jan.
1794, 8.188, J E Smith Manuscripts, Linnean.
43Andreas-Holger Maehle, Drugs on trial:
experimental pharmacology and therapeutic
innovation in the eighteenth century, Clio Medica,
vol. 53, Amsterdam, Rodopi, 1999, pp. 287–8.
44Want of tone: enervation, languor.
45Roxburgh, op. cit., note 15 above, p. 18.
46Ibid., p. 24.
47William Roxburgh to the Madras Government,
30 Aug. 1791, MSS. Eur F.18 (I) K148, APAC. For a
detailed analysis of problems of metropolitan
recognition for peripheral scientists, see
P Chakrabarti, Western science in modern India,
metropolitan methods, colonial practices, New Delhi,
Permanent Black, 2004, pp. 60–93.
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82publishing material from his (Roxburgh’s) collections without asking permission.
Roxburgh had sent Dalrymple a paper on Swietenia together with a letter addressed to
the Court of Directors, and Dalrymple had appropriated some of Roxburgh’s comments
in his own publications, without proper acknowledgment.
48
Roxbrugh faced other professional constraints. When Banks finally replied in 1796
about the potential of the new bark in England, he was rather pessimistic about its accep-
tance there, not because of its scientific value, but for professional reasons. Banks com-
mented candidly and rather critically on physicians in England and their lack of
enthusiasm for “new” knowledge,
I rejoice to hear that your Swietenia Bark gains credit in India. Here it’s scarce possible for a new
medicine to gain a place in the Dispensary. Physicians here who gain more in a week probably than
they deserve in a year care not how few medicines their Materia Medica is composed of, the fewer
their number the less expense of thought in making use of them.
49
In addition to this, investigation into alternatives to cinchona was a highly competitive
field in contemporary England. Banks himself was engaged in its study. Aylmer Bourke
Lambert published his Description of the genus Cinchona in 1797, which he dedicated to
Banks with the words, “by whose liberal and Friendly communications accompanied by
Original Drawings and Specimens from His Herbarium this work has been so Amply
Enriched”.
50 Lambert was a British botanist who assembled an important herbarium
and library which were sold after his death. His major work was A description of the
genus Pinus. Both Banks and Smith, Roxburgh’s two contacts in England, were impor-
tant advisers to this scholarly publication.
51
Banks’s scepticism about the acceptance of new medicine in England was significant.
Although he and others had built a global network of natural history and accumulated a
large number of specimens, he was aware that interest in them in Europe, and therefore
the likelihood of their acceptance, was declining. This intellectual conservatism is a
critical factor in the history of alternatives.
Swietenia and the Cinchona Substitutes
Even in India, Swietenia was just one of the many substitutes for the Peruvian bark
found by colonial medical men. Such finds were the product of a wide intellectual and
cultural enterprise undertaken in different parts of the country. There was, for instance,
the Cæsalpinia bonducella, more popularly known as Catcaranja. John Fleming, another
48Ibid., p. 244. Roxburgh’s aspersions about
Dalrymple perhaps had some grounds. A socially
ambitious man, Dalrymple, after a career in the
colonies, had by this time established his position in
London. He was a close friend of Joseph Banks and a
regular member of the Royal Society club, dining
weekly under Banks’s chairmanship, Andrew S Cook,
‘Dalrymple, Alexander (1737–1808)’, Oxford
Dictionary of National Biography, http://www.
oxforddnb.com/view/article/7044, accessed
4 Aug 2005.
49JosephBankstoAndrew Roxburgh, 29May1796,
Banks correspondence, BL Add. MS 33980, fol. 65.
50A B Lambert, A description of the genus
Cinchona ...illustrated by figures of all the species
hitherto discovered. To which is prefixed Professor
Vahl’s dissertation on this genus ...Also a
description accompanied by figures of a new genus
named hyænanche, or, hyæna poison, London,
B & J White, 1797, title-page.
51Banks correspondence, BL Add. MS 33980,
fols 121–4.
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83EEIC surgeon, wrote in his ‘Catalogue of Indian medicinal plants’ that although it was
found in both the East and the West Indies, its medicinal values were appreciated only
in the East, particularly its bitter tonic qualities. Here it was “employed by the Hindu
physicians, in all cases in which that power is more especially required; and particularly
in intermittent fevers, for which they are considered as an almost infallible remedy”.
52
He added,
It has been adopted by many European practitioners, particularly in those cases which so frequently
occur, in which the patients have an aversion to the Peruvian bark ...In all such cases, and also on
occasions where the Peruvian bark cannot be procured, I believe that the Catcaranja will be found
one of the best substitutes to which we can have recourse.
53
Another substitute was Menispermum cordifolium / verrucosum, also referred to by Hein-
rich van Rheede as Cit-amerdu.
54 Fleming stated that Hindu physicians prescribed the
decoction of the leaves as a febrifuge as well as a cure for jaundice.
55 In Sylhet, Bengal,
a species of Hymenodictyon was found, which, according to the surgeon J Forbes Royle,
“affords a set of interesting facts, as these are all nearly allied to the valuable medicinal
genus Cinchona”.
56
Another substitute for cinchona was found by John Kennedy, surgeon to the third batta-
lion of native infantry. In a letterto the Edinburgh based physician, Andrew Duncan (junior)
in 1795, Kennedy gave an account of a febrifuge bark that he had found in Chunar (40 km
from Varanasi, Uttar Pradesh). He had earlier met Roxburgh at Samulcottah and collected
the Swietenia bark and found it useful in a number of cases. But being posted at Chunar
Garh, “far distant from the source of supply [of the Swietenia bark]” he started looking
for local substitutes and experimented with the bark of the “toon-tree” (Cedrela toona),
and discovered that “it possessed qualities approximating to Dr Roxburgh’s bark”. He
then used it widely in his medical practice both in the form of powder and of extract in their
simple state, “From all these different forms, I have found great advantage in the cure of
fevers, and of different kind of ulcers, whether venereal or of the simple vitiated kind.”
57
Kennedy found it to be particularly useful when used with Catcaranja. He sent a sample
of the bark, some extracts, as well as some of the Catcaranja to Duncan. He also enclosed
a letter from Roxburgh recognizing the virtue of the “Toon bark”.
58 Roxburgh later found
the toon tree in plenty in the botanical garden at Calcutta and acknowledged that it was
“possessed of sensible qualities nearly equal to mine”.
59 Kennedy ended his piece expres-
sing his hope of its success in Europe, “the toon-tree-bark, upon its trial in Europe, may cor-
respond with the account I have given of its medical virtues”.
60
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84There is some confusion regarding the botanical and ethnological roots of the
Swietenia. Roxburgh claimed to have collected the species from the forests of the Rajah-
mundry region, in present Andhra Pradesh. He did not specify how he became aware
of the medical virtues of the bark or whether local people used it for medicinal
purposes. There is some evidence that it was customarily used as a medicine. Forbes
mentioned that Soymida was traditionally “reckoned a good stomachic and powerful
febrifuge”, and the bark of Cedrela toona, a congener, as well as that of Chikrassee
was used as an astringent.
61 In John A Parrotta’s Healing plants of peninsular India,
the Soymida is described as “a popular drug in traditional Indian medicine, and is cred-
ited with antiperiodic properties”. It was used in the treatment of diarrhoea, dysentery,
and intermittent fevers.
62
Similar confusion existed regarding the celebrated cinchona bark as well, which shows
how the history of febrifuge barks was closely linked with the intellectual and material
interests of colonialism. The barks held an important clue to European imperial interests
in the tropics and their proprietorship was thus intensely contested. There was uncer-
tainty regarding both the species from which the cinchona bark was taken and the origins
of its use in intermittent fevers. It was in the seventeenth century that a monk of the
Augustinian order became aware of its medicinal qualities, having apparently been
informed by the locals, as he noted, “A tree grows which they call ‘the fever tree’ in
the country of Loxa”.
63 A piece published in the Philosophical Transactions in 1737
by John Gray also confirmed this view. According to him, William Arrot, a Scottish sur-
geon who collected the bark from Peru commented that “its Qualities and Use were
known to the Indians before ever any Spaniard came among them; and that it was by
them applied in the Cure of intermittent Fevers, which are frequent over all that wet
and unhealthy country”.
64
However, according to the British geographer and “adventurer” Clements R Markham,
who secretly collected the seedlings from Peru, deceiving the local inhabitants and
authorities, and then propagated it in the Empire,
65 its medicinal virtues were, if at all,
known only around Loxa, and even there the indigenous people “attached little impor-
tance to them”.
66 Inhabitants of other areas like the province of Huanuco had “a strong
repugnance to its use”. According to Markham this could be explained by their under-
standing of diseases in terms of heat or cold, and they believed the bark to be very effec-
tive in inducing heat, which also explained, in his opinion, “their prejudice against its use
61Royle, op. cit., note 56 above, p. 143.
62John A Parrotta, Healing plants of peninsular
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Swietenia febrifuga and the Cinchona Substitutes
85in fevers”.
67 It has also been debated whether malaria, in the treatment of which
cinchona was found to be revolutionary, existed in the New World before the advent
of the Spanish. Markham put forward the argument that the disease was not to be found
in the pre-Columbian Americas and also that the bark was absent in the materia medica
of the Incas.
68 But Duran-Reynals suggests that in the several years between the arrival
of the Spanish, who supposedly brought malaria to these parts, and the European discov-
ery of cinchona, the inhabitants of the forests might have independently developed the
cure for the disease. There is evidence to show that a great degree of interaction
took place between local healers, their curative plants and treatments, and the Europeans
during this period.
69
Until the nineteenth century, the species Cinchona itself was perplexing. As another
Madras-based EEIC surgeon, Whitelaw Ainslie, commented, “The genus cinchona, of
which twenty-four species have been described, Mr. Thomas, with much truth, observes
is still involved in considerable ambiguity.”
70 He also mentioned that similar plants were
found in Siam (Thailand). Ainslie pointed out the general problems encountered in iden-
tifying such medicines and plants from Eastern markets, “the imperfect condition in
which a great many of the medicines are found in the bazaars; old, dry, and not seldom
decayed. I have frequently been obliged to take on trust a description of their character-
izing taste and smell; at other times, the root, or bark, or leaf, called for, was not to be
found”.
71 Forbes Royle discussed the problem of identifying the true medicinal species
of distant lands:
Though the extent and distribution of the true Cinchonas has been pretty well ascertained, there is
yet considerable obscurity respecting the species which yield the different official barks, owing
partly to incomplete investigation, but chiefly to the natives uniting them according to physical
properties, which vary even upon the same tree, according to age and exposure ...
72
In Britain, similar confusion remained as Andrew Duncan (junior) indicated,
“Notwithstanding that all the British colleges agree in the botanical species of Cinchona,
from which the commercial varieties of bark are derived, there is no satisfactory evi-
dence that they are right; on the contrary, it is almost certain that in regard to some of
them they are wrong.”
73
Another problem was the identification of the “true” species that produced the best
cinchona bark. The genus Cinchona included over thirty species, which grew in scattered
clumps in the forests of Colombia, Ecuador, Peru and Bolivia, each varying widely in
terms of colour and alkaloids.
74 Such confusion about the origins and therapeutic value
of the tree provided botanists like Roxburgh and Wright with the opportunity to look for
local alternatives in the British colonies. Many of these barks were subjected to trials to
clarify their origin and therapeutic value.
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86The Trials of Swietenia
The next episode of the Swietenia story concerns its trials in Europe. John Fleming
noted its success in hospitals in Britain, where it was “considered as a valuable substi-
tute, in many cases of the cinchona”. Additionally, the Edinburgh College included it
in their pharmacopoeia.
75 However, Roxburgh’s bark never, in fact, gained acceptance
in Europe, although Andrew Duncan (senior) seems to have tried it in his infirmary in
Edinburgh with some success.
76 Personal ambitions and commercial pressures played
an important role in these European trials, and there was also a bias for locally developed
astringents. Johannes Fawssett in Edinburgh (who wrote the Dissertatio medica inaugu-
ralis de febribus intermittentibus medendis, 1798), advocated a combination of the
astringent bistorta and the bitter calamus aromaticus in Swietenia’s place. He claimed
this had been successful in “almost a hundred cases” of intermittent fever in Horncastle
Hospital, Lincoln, and was even better than the yellow bark.
77
The main factor in the lack of proper scientific recognition in Europe for these differ-
ent specimens was their unfamiliarity and their physical state when they reached Europe.
The transfer of seeds, living plants, insects and animals across the oceans to England
involved several hazards. Sea captains were not careful about their scientific cargo;
plants died in the holds for lack of sunshine, and dried specimens were mixed up.
78 In
1730, Dr James Douglass described the problems of studying these plants in England,
“as these Roots are never imported to us entire, it is impossible to give any certain
Description of them in that State”.
79 Hans Sloane commented on how difficult it was
to identify barks in London, particularly those coming from distant countries. Henry
Barham, the Jamaica-based physician, had sent him a variety of the Apocynum erectum,
commonly called Blood Flower in Jamaica (for its use in stopping blood, “when other
medicines fail’d”). The plant was eminently useful according to Barham; the juice
injected by a syringe stopped the bleeding of piles; a decoction of the leaves, stalks
and flowers cured running gonorrhoea. The same root had been sent to Sloane, many
years previously, from Virginia so that “a commerce [be] established for it”. But “not
knowing what mischief might ensue from the Use of an unknown Root” he had disposed
of it.
80 Dr Burnet, who was sent by the South Sea Company to take care of their factory
at Port Belo, had sent him a draught of the same Apocynum and an account of how the
Spanish and other inhabitants used that root instead of ipecacuanha. This was followed
by Barham’s despatch of the same species. Still uncertain about its medical virtues,
Sloane now referred it to the College of Physicians and the Company of Apothecaries.
He also showed them the various specimens that he had received and the differences
between this species and the true ipecacuanha. After observing the physical differences
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87between the varieties, the Company of Apothecaries chose “to condemn and destroy such
a dangerous root”, which led to Sloane’s rejecting it as well, adding, “there is wide dif-
ference between fresh roots and those dried and that often one is not sure whether one
has picked the right one”. Since many unknown roots were indeed very poisonous he
was reluctant to be “the first Experimenter of such a Matter, either upon myself or any-
body else”.
81 According to him, the “Gumm Guajacum” of the West Indies, if not col-
lected properly could also be poisonous.
82
Another instance of the confusion surrounding medical specimens sent from the colo-
nies related to the cabbage tree bark. William Wright and others in Jamaica had learnt
from the slaves about the use of the bark for curing worms. Wright had sent specimens
to Edinburgh and the cabbage tree bark was used as an antithelminthic by several practi-
tioners there. However, they complained of the “violence of its operation”, both as an
emetic and a cathartic.
83 As a result, Edinburgh physicians did not think that “it will
ever be soon introduced into common use”.
84 In a letter to Andrew Duncan (senior),
William Anderson, who had worked in the West Indies as a surgeon, defended this
bark, describing his own experiments with it, and highlighting the problems of researches
done in England on specimens from distant lands:
I think it would be unfortunate, were it rejected without a fair trial. The hazardous symptoms which
have been ascribed to it may, I imagine, have followed either from the use of the first kind [a paler
variety which is not effective], or from an over dose. Both the one, and the other of these circum-
stances, however, might easily be guarded against ...I must observe that I never saw it act vio-
lently when thus managed; while, at the same time, I have often experienced the best effects
from it as a powerful anthelmintic [sic].
85
Wright too observed that although doctors in Edinburgh found that the bark of the cab-
bage tree caused nausea, this was never the case in Jamaica, and was probably due to the
“mouldy state” of the specimens after the long voyage.
86
The same applied to Swietenia. Andrew Duncan (junior) based his dissertation on
Swietenia bark on the samples sent to Edinburgh by Roxburgh. He, however, never saw
the bark in its original form and depended on Roxburgh’s descriptions of it.
87 Later in
his Edinburgh new dispensatory he wrote that that the Swietenia barks he had with him
wereinsucha condition thattheycouldnotbedistinguished fromthe“kino ofthe shops”.
88
By the end of the eighteenth century, however, developments in science were to
resolve many of these problems of ambiguity as well as of the enmeshed ethnologies
of these plants. Maehle has argued that the increasing reliance upon contemporary
pharmacological explanations by European practitioners “eroded” cinchona’s status as
81Ibid., p. xii.
82Ibid., p. xii.
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88a “specific” against intermittent fever, leading instead to its recommended use against a
broader array of diseases including gangrene, ulcers, and smallpox. Its efficacy in treat-
ing both internally and externally manifest diseases allowed cinchona to become a cen-
tral therapeutic agent for both physicians and surgeons.
89 However, this explanation for
the emergence of cinchona as a panacea is inadequate. As discussed above, many of its
substitutes also demonstrated a similarly broad therapeutic value. The pre-eminence of
cinchona, as we shall see, was achieved by a general process of sifting which had
evolved in European science, through which the entire problematic of medical alterna-
tives was being resolved.
Cinchona and the Search for the “Active Principle”
The search for the “active principle” is where the fulcrum of this history is located. As
the use of cinchona spread throughout Europe, apothecaries and chemists began to ques-
tion which specific substance contained in the Peruvian bark and its substitutes was
active against intermittent fevers. Sustained efforts were, therefore, made around 1800,
to identify the “active principle” of the bark. In his Dispensatory, Duncan (junior), for
example, expressed a desire to reveal the true essence of cinchona, “the preparation of
an extract of cinchona, which may contain its active principles in a concentrated form,
is a desirable object”.
90 The identification of an active principle was important, first,
to reduce dependency on unscrupulous traders who often provided fake samples; second,
as even the real bark varied in potency, extracting the active agent could also standardize
the dosage. Armand Seguin, in his ‘Memoir on the febrifuge principle of cinchona’,
made the rationale of the project clear, the uncertainties of taste and smell of the medi-
cines of distant lands were to be distilled by chemistry:
Hitherto the sight and taste have been the only tests of the presumable qualities of the Peruvian
bark of the shops; but as these have no precise standard, and are inapplicable to powdered bark,
89Maehle, op. cit., note 43 above, p. 258.
90Duncan, op. cit., note 88 above. Duncan
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89they very imperfectly indicate the presence of the febrifuge principle. It was of importance, there-
fore, to substitute to these means, little better than illusory, others not only capable of calculation,
but likewise invariable. Chemical re-agents alone can answer these ends.
91
This was part of a greater change in eighteenth-century science, sometimes referred to as
the “Chemical Revolution”, initiated by Antoine Lavoisier in France. Lavoisier devel-
oped a new chemical taxonomy as well as a radically new understanding of all elements
and compounds. Through these new modes, experimental chemistry had become a prime
gentlemanly pursuit in eighteenth-century Europe. This new approach also shaped the
public culture around science,
92 and, additionally, developments in medical knowledge.
In 1779, the French chemists J B M Bucquet and C M Cornette announced that they
had successfully extracted the “essential salt” of cinchona.
93 In 1790, another French
chemist, Antoine Fran¸ cois Fourcroy, discovered the existence of a “colouring” matter
(a resinous substance with the characteristic colour of the bark) and for some time main-
tained that he had isolated the active principle.
94 Seguin had come to the conclusion that
the active principle in cinchona was gelatine.
95 Duncan (junior), who had entered the
field of astringent barks with his doctoral dissertation,
96 wrote a letter to Nicholson’s
journal rejecting Seguin’s claims and maintaining that he was the first to suggest that
a real substance existed as a febrifuge principle.
97 Duncan’s letter stressed that the pre-
sence of gelatine in cinchona was incompatible with his own experiments and conjec-
tured that Seguin’s sample of the bark was probably adulterated. He proposed that the
essential principle in cinchona was different from any hitherto described and that it be
distinguished “by the title of Cinchonin”.
98 Cinchonin was an alkaloid (C19H22N2O)
that Duncan derived from the bark of various cinchona trees for use as a febrifugal agent.
Duncan also admitted that while his experiments showed that cinchonin was different
from gelatine, it was not necessarily the essential febrifuge principle, which would be
investigated in future experiments, “Experiments alone, however, can ascertain the point,
as well as whether the febrifuge effects of cinchona depend upon the cinchonin alone, or
upon the peculiar combination of principles which exist in it.”
99 Yet, cinchonin seemed
to hold some clues in identifying the essential principle of many confusing anti-malarial
astringents, as well as ipecacuanha, columba, and angustura.
100 Accordingly, Duncan
suggested determining the cinchonin content of different barks to assess their quality.
In the Swietenia bark, he did not find any cinchonin in 1803.
101
The next phase of development began some thirteen years later. According to
Markham, it was Dr Gomez, a surgeon in the Portuguese navy, who was the first to iso-
late the active principle and “he called it chinchonine”.
102 This seems initially to have
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90been the general assumption, as Duncan (junoir) later took pains to establish that it was
he who was the first to discover the essential principle of cinchona bark.
103 In 1820, the
French chemists P J Pelletier and J B Caventou finally discovered that the febrifuge prin-
ciple was actually present in two alkaloids, called quinine and cinchonine, with the same
virtues, but much more powerfully in quinine.
104 Writing on this in 1829, Duncan com-
mented that Pelletier and Caventou’s discovery of quinia and the salts formed by acids
with both bases “completed our knowledge of the essential principles of cinchona bark”.
But he was careful to point out that his claim as the “first discoverer of the essential prin-
ciple of cinchona bark is now fully admitted by the French chemists”, although “it was
long erroneously ascribed to Gomes [sic]”.
105 Cinchonin never became an antidote for
malarial fever.
A similar solution to the problem of diverse forms of ipecacuanha was provided by the
search for its active principle. Following the studies by Dr Ralph Irving (1784), M Henry
and M Masson-Four, it was again Pelletier in 1822 who identified emetine in which it
was believed “the active virtue of ipecacuanha exclusively resides”, thus resolving the
confusion.
106
The most significant result of the advances in the chemical knowledge of cinchona
was that the search for alternatives became almost obsolete. Swietenia was not the
only bark or remedy to be thus discarded, but its fate is illustrative of those found in
the colonies, tested through local means and networks, and which were, for a time, con-
sidered to be important cures. Yet they dropped out of the scientific reckoning with chan-
ging paradigms. Thus with the shift to the chemical search for the “active principle”, the
quest for alternatives for the cinchona bark became almost irrelevant. The new research
into the “active principle” never materialized in colonial scientific activities. Scientists in
the colonies continued to look for alternatives at a time when those in Europe had
made the breakthrough, and thus a hierarchy and monopoly around the Peruvian bark
had been created. The year following Caventou’s discovery of quinine,t h eMedical and
Chirurgical Transactions published a long article by P Breton, assistant surgeon to the
Rampur Battalion, on the Swietenia febrifuga.
107 Breton did not mention the active princi-
ple, but detailed how, following Roxburgh, he had taken up research on the bark, and
described the positive results encountered by him and several other surgeons in different
parts of India when using it to treat intermittent fevers, gangrene and bilious problems. He
once again asserted that Swietenia was “an efficient substitute for the Peruvian bark”. His
plea for the scientific recognition of the bark, although now redundant, was nevertheless
poignant:
If this bark shall be ultimately proved, (as I am almost certain it will,) equal in effect to the cin-
chona, the benefit that will result from it to Great Britain, and her vast dependencies in the East, espe-
cially in the present precarious state of our actual relations with America, will be incalculable.
108
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91Swietenia continued to be available in Indian bazaars with a reputation for curing inter-
mittent fevers.
109
As a footnote to all this, a rather inconsequential letter from William Twining, an
EEIC surgeon, sent to Nathaniel Wallich (superintendent of the Calcutta Botanical
Garden, Roxburgh’s successor) in 1834, mentioned that William O’Shaughnessy
(surgeon of the EEIC, shortly to become professor of chemistry and medicine at
the Calcutta Medical College) had experimented on the Neem and Rohuna barks
(the names sometimes used for the Soymida in north India) and had found no traces
of quinine in either, adding, “This is what you predicted of O’Shaughnessy’s experi-
ments.”
110 However, there is some doubt about this as well; another British surgeon
Edward Waring later wrote that what was often sold in the Indian bazaars under the
name of “Rohuna” was in fact the Nux vomica bark. He also claimed that although
O’Shaughnessy “speaks slightingly of its [Swietenia’s] powers” his opinion was
based “rather on theoretical grounds than on actual trials with it”.
111 So the efficacy
of Swietenia remained unclear. This ambiguity is indicative of its status in modern
medicine, which had found the panacea.
Conclusion
While peripheral networks gathered much information, verified claims and facili-
tated experiments, they did not ensure the scientificity of knowledge. The scientific
motivations in the distant colonies were not always in tune with those of the metro-
polis. Londa Schiebinger has analysed a similar metropolitan rejection of a colonial
medical item in her study of the peacock fl o w e ru s e da sa na b o r t i f a c i e n tb ys l a v e
w o m e ni nt h eW e s tI n d i e s .
112 When brought to Europe, the knowledge of its aborti-
facient properties failed to make the voyage and it never received recognition in
Europe. Schiebinger attributes this rejection to the attitude of the scientific elites
of Europe towards gender and female bodies. Researches on such topics were not
considered prestigious enough. Moreover, abortifacients remained a problematic poli-
tical and religious topic in Europe, thereby inhibiting the knowledge of such New
World medicinal plants. Although the issue of gender was a crucial factor in this
case, I wish to suggest that rejections of colonial medical items were taking place
at a general level as well as within a wider politics of scientific sifting. The rejec-
tions were not just of a bark or of its ethnology and history, but also of the various
modes of understanding that had been nurtured in the colony.
While Europe from the seventeenth century was being flooded with exotic and
alternative medicinal plants collected through networks in the colonies and beyond, its
109E J Waring, Pharmacopeia of India, prepared
under the authority of Her Majesty’s Secretary of
State in India in Council, London, W H Allen, 1868,
p. 55.
110W Twining to N Wallich, 8 July 1834, Wallich
Correspondences (1833–1835) (Box 19), Calcutta
Botanical Garden Library.
111Waring, op. cit., note 109 above, pp. 444–5.
112Londa Schiebinger, Plants and empire:
colonial bioprospecting in the Atlantic world,
Cambridge, MA, Harvard University Press, 2004.
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92scientific institutions were simultaneously subjecting them to new forms of scrutiny,
sometimes rendering the items and the networks irrelevant and ineffective to the new
tradition. This reflects the centripetalism of science in the age of empire and expansion.
To return to the problem of periphery and metropolis in colonial science, this paper has
argued that the scientific practices of the periphery were no less creative or persevering
than those of the metropolis, but that the determinants of modern science, and thereby its
truth, lay elsewhere.
How far did the discovery of quinine help to identify cinchona or the Peruvian bark as
the key species for malarial treatment and end the search for alternatives? The years after
1820 saw a great rush in Europe to acquire cinchona and to grow it in habitable condi-
tions elsewhere. As Ray Desmond has stated, “The extraction of the alkaloid quinine
by two French chemists in 1820 made medical history. Cinchona became a coveted plant
for nations like Britain and the Netherlands with colonies in the tropics where malaria
was endemic.”
113 Soon the logic of alternatives was replaced by that of transplantation.
Supporting the introduction of cinchona to India and discussing the “Value of Quinine”,
Markham wrote,
India and other countries have been vainly searched for a substitute for quinine, and we may say
with as much truth now as Laubert did in 1820—“this medicine, the most precious of all those
known in the art of healing, is one of the greatest conquests made by man over the vegetable king-
dom. The treasures which Peru yields, and which the Spaniards sought and dug out of the bowels
of the earth, are not to be compared for utility with the bark of the quin-quina-tree, which they for a
long time ignored”.
114
To put the issue of Swietenia / Soymida and other barks in perspective, a brief over-
view of the introduction of cinchona into India will be useful. After the discovery
of quinine, several scientists and botanists working in the subcontinent, such as
Royle, Hugh Falconer, Henry Piddington and others, had argued for the introduction
of cinchona plantations. They suggested several sites like the hills of North Bengal
and the Nilgiri mountains.
115 Markham finally introduced the Bolivian and Peruvian
varieties to India in the Nilgiris in 1861.
116 The alternatives to cinchona that
were being locally recommended for plantation were disregarded. When the Agri-
Horticultural Society of India proposed the introduction of cinchona in 1857 they
also appealed to the authorities for a trial of Atees or Atibisha or Aconite (Aconitum
heterophyllum, A. forex etc.) as an antidote to malaria. Wallich had noted in his Plantæ
asiaticæ rariores (1832) that this plant had been used in India for centuries for inter-
mittent fevers and was an ideal alternative to cinchona. As one member of the
113Ray Desmond, The European discovery of the
Indian flora, Oxford University Press and Royal
Botanic Gardens, 1992, p. 222.
114Markham, op. cit., note 66 above,
pp. 34–5.
115Abhijit Mukherjee, ‘The Peruvian bark
revisited: a critique of British cinchona policy in
colonial India’, Bengal Past and Present, 1998,
117: 81–102, on pp. 84–5.
116Williams, op. cit., note 13 above, pp. 431–42.
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93Agri-Horticultural Society wrote in 1857, “I do not consider Atees a panacea, it must
fail sometimes as other remedies do, even quinine itself, but that it is the substitute for
quinine is not the slightest doubt in my opinion.”
117 However, from the metropolitan
and imperial perspective, cinchona had already become the panacea and the search
for alternatives was over.
117Letter from Mr Henning, assistant surgeon,
Oorai, to Cecil Beadon, secretary to the government
of Bengal, undated, J. Agr. Hortic. Soc. India,
1857, 9: cclix, quoted in Mukherjee, op. cit., note 115
above, p. 97.
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